123 related articles for article (PubMed ID: 37311498)
1. Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation.
Rizwanullah M; Perwez A; Alam M; Ahmad S; Mir SR; Rizvi MMA; Amin S
Int J Pharm; 2023 Jul; 642():123136. PubMed ID: 37311498
[TBL] [Abstract][Full Text] [Related]
2. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization,
Rizwanullah M; Perwez A; Mir SR; Alam Rizvi MM; Amin S
Nanotechnology; 2021 Jul; 32(41):. PubMed ID: 34198267
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
Singh A; Neupane YR; Mangla B; Kohli K
J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
[TBL] [Abstract][Full Text] [Related]
4. Polymer-Lipid Hybrid Nanoparticles: A Next-Generation Nanocarrier for Targeted Treatment of Solid Tumors.
Rizwanullah M; Alam M; Harshita ; Mir SR; Rizvi MMA; Amin S
Curr Pharm Des; 2020; 26(11):1206-1215. PubMed ID: 31951163
[TBL] [Abstract][Full Text] [Related]
5. QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer.
Singh P; Alka ; Maurya P; Nisha R; Singh N; Parashar P; Mishra N; Pal RR; Saraf SA
J Liposome Res; 2023 Jun; 33(2):154-169. PubMed ID: 35930249
[TBL] [Abstract][Full Text] [Related]
6. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane.
Amaral C; Augusto TV; Almada M; Cunha SC; Correia-da-Silva G; Teixeira N
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165661. PubMed ID: 31891807
[TBL] [Abstract][Full Text] [Related]
7. The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats.
Goss PE; Qi S; Josse RG; Pritzker KP; Mendes M; Hu H; Waldman SD; Grynpas MD
Bone; 2004 Mar; 34(3):384-92. PubMed ID: 15003786
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic effects of exemestane in premenopausal breast cancer model.
Kubatka P; Sadlonova V; Kajo K; Machalekova K; Ostatnikova D; Nosalova G; Fetisovova Z
Neoplasma; 2008; 55(6):538-43. PubMed ID: 18999884
[TBL] [Abstract][Full Text] [Related]
9. Hormone-dependent breast cancer: Targeting autophagy and PI3K overcomes Exemestane-acquired resistance.
Amaral C; Augusto TV; Tavares-da-Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2018 Oct; 183():51-61. PubMed ID: 29791862
[TBL] [Abstract][Full Text] [Related]
10. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.
Pritchard KI; Burris HA; Ito Y; Rugo HS; Dakhil S; Hortobagyi GN; Campone M; Csöszi T; Baselga J; Puttawibul P; Piccart M; Heng D; Noguchi S; Srimuninnimit V; Bourgeois H; Gonzalez Martin A; Osborne K; Panneerselvam A; Taran T; Sahmoud T; Gnant M
Clin Breast Cancer; 2013 Dec; 13(6):421-432.e8. PubMed ID: 24267730
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the weak estrogen receptor alpha agonistic activity of exemestane.
Masri S; Lui K; Phung S; Ye J; Zhou D; Wang X; Chen S
Breast Cancer Res Treat; 2009 Aug; 116(3):461-70. PubMed ID: 18677558
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life and disease symptoms in postmenopausal women with HR(+), HER2(-) advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy.
Campone M; Beck JT; Gnant M; Neven P; Pritchard KI; Bachelot T; Provencher L; Rugo HS; Piccart M; Hortobagyi GN; Nunzi M; Heng DY; Baselga J; Komorowski A; Noguchi S; Horiguchi J; Bennett L; Ziemiecki R; Zhang J; Cahana A; Taran T; Sahmoud T; Burris HA
Curr Med Res Opin; 2013 Nov; 29(11):1463-73. PubMed ID: 23962028
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of sequential treatment with anastrozole following exemestane compared with exemestane following anastrozole in patients with metastatic breast cancer].
Ikeda M; Kurebayashi J; Sonoo H; Miyake A; Nomura T; Yamamoto Y; Shiiki S; Nakashima K; Tanaka K
Gan To Kagaku Ryoho; 2008 Feb; 35(2):261-5. PubMed ID: 18281762
[TBL] [Abstract][Full Text] [Related]
15. Alternative oral exemestane formulation: improved dissolution and permeation.
Yavuz B; Bilensoy E; Vural I; Sumnu M
Int J Pharm; 2010 Oct; 398(1-2):137-45. PubMed ID: 20678561
[TBL] [Abstract][Full Text] [Related]
16. Influence of Glutathione-S-Transferase A1*B Allele on the Metabolism of the Aromatase Inhibitor, Exemestane, in Human Liver Cytosols and in Patients Treated With Exemestane.
Teslenko I; Trudeau J; Luo S; Watson CJW; Chen G; Truica CI; Lazarus P
J Pharmacol Exp Ther; 2022 Sep; 382(3):327-334. PubMed ID: 35793834
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.
Burris HA; Lebrun F; Rugo HS; Beck JT; Piccart M; Neven P; Baselga J; Petrakova K; Hortobagyi GN; Komorowski A; Chouinard E; Young R; Gnant M; Pritchard KI; Bennett L; Ricci JF; Bauly H; Taran T; Sahmoud T; Noguchi S
Cancer; 2013 May; 119(10):1908-15. PubMed ID: 23504821
[TBL] [Abstract][Full Text] [Related]
18. Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
Kaufmann M; Bajetta E; Dirix LY; Fein LE; Jones SE; Zilembo N; Dugardyn JL; Nasurdi C; Mennel RG; Cervek J; Fowst C; Polli A; di Salle E; Arkhipov A; Piscitelli G; Miller LL; Massimini G
J Clin Oncol; 2000 Apr; 18(7):1399-411. PubMed ID: 10735887
[TBL] [Abstract][Full Text] [Related]
19. Lyophilized mixed micelles of exemestane: A novel paradigm to improve its absorption and anticancer activity.
Singh G; Kaur P; Singh D; Tiwary AK; Arora S; Bedi N
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2200579. PubMed ID: 37276367
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
